1211.5000 12.80 (1.07%)
NSE Nov 11, 2025 15:31 PM
Volume: 1.0M
 

1211.50
1.07%
ICICI Direct
About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Number of FII/FPI investors decreased from 917 to 872 in Sep 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended